作者：
Coelho,T. [1]
;
Adams,D. [2]
;
Silva,A. [3]
;
Lozeron,P. [4]
;
Hawkins,P.N. [5]
;
Mant,T. [6]
;
Perez,J. [7]
;
Chiesa,J. [8]
;
Warrington,S. ;
Tranter,E. ;
Munisamy,M. ;
Falzone,R. ;
Harrop,J. ;
Cehelsky,J. ;
Bettencourt,B.R. ;
Geissler,M. ;
Butler,J.S. ;
Sehgal,A. ;
Meyers,R.E. ;
Chen,Q. ;
Borland,T. ;
Hutabarat,R.M. ;
Clausen,V.A. ;
Alvarez,R. ;
Fitzgerald,K. ;
Gamba-Vitalo,C. ;
Nochur,S.V. ;
Vaishnaw,A.K. ;
Sah,D.W.Y. ;
Gollob,J.A. ;
Suhr,O.B.
作者单位：
National Amyloidosis Centre, Royal Free Hospital, London, United Kingdom
[1]
Quintiles Limited, Guy's Drug Research Unit, London, United Kingdom
[2]
Alnylam Pharmaceuticals, Cambridge, MA, United States
[3]
Hammersmith Medicine Research, London, United Kingdom
[4]
Department of Public Health and Clinical Medicine, Ume? University, Ume?, Sweden
[5]
Université Paris-Sud, H?pital de Bicêtre, INSERM Unité 788, Paris, France
[6]
Covance Clinical Research Unit, Leeds, United Kingdom
[7]
Unidade Clinica de Paramiloidose, Hospital de Santo Antonio, Instalacoes do Ex-CICAP, Rua D. Manuel
[8]
发布时间
2018-10-31
换一批
